Dosage form development, manufacture, and stability studies of AVE-1625 (DRINABANT)
Ended Awarded Last action
- Contract number
- 75N95020F00001
- Awardee
-
Societal Cdmo San Diego, LLC UEI YRPTVKHDL7Z5
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $704,622
Award facts
- Opportunity
-
- CRO Support for NCATS Drug Product Development, Manufacture, and Stability Studies Pre-Solicitation · 75N95020R00044 · Posted Jul 21, 2016
- Contract value 100% obligated
- $704,621.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | -$367,829 | |
| Change Order | $79,600 | |
| Change Order | $39,000 | |
| Supplemental Agreement for work within scope | $105,150 | |
| Original award | $848,700 |
About this award
This is a delivery order contract awarded by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to Societal CDMO San Diego, LLC (doing business as Irisys Inc.), a self-certified small disadvantaged business. The $704,621.50 firm-fixed-price contract is for the dosage form development, manufacture, and stability studies of the investigational drug AVE-1625 (drinabant). The work is being performed in San Diego, California.
This delivery order is under the $45 million NCATS Drug Product Development Studies 2017-2022 indefinite delivery, indefinite quantity (IDIQ) contract vehicle, which provides pharmaceutical development and manufacturing services to support NIH/HHS agencies like the National Cancer Institute in their translational research and clinical studies. Societal CDMO has held several other IDIQ contracts with federal agencies like the Department of Veterans Affairs to manufacture and supply drug products for clinical trials.
Quick answers
Who was awarded contract 75N95020F00001?
75N95020F00001 was awarded to Societal Cdmo San Diego, LLC by National Institute on Drug Abuse (National Institutes of Health) on September 23, 2020.
How much is contract 75N95020F00001 worth?
The government has obligated $704,622 on 75N95020F00001.
Which agency awarded contract 75N95020F00001?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95020F00001, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Is contract 75N95020F00001 an order under another contract?
Yes. 75N95020F00001 is a delivery order under HHSN271201700020I, an indefinite delivery contract, on NCATS Drug Product Development Studies 2017-2022.
Was contract 75N95020F00001 competed?
The extent of competition for 75N95020F00001 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award